281 related articles for article (PubMed ID: 29101176)
1. VEGF nanoparticles repair the heart after myocardial infarction.
Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
[TBL] [Abstract][Full Text] [Related]
2. Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.
Chung HJ; Kim JT; Kim HJ; Kyung HW; Katila P; Lee JH; Yang TH; Yang YI; Lee SJ
J Control Release; 2015 May; 205():218-30. PubMed ID: 25681051
[TBL] [Abstract][Full Text] [Related]
3. Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.
Awada HK; Johnson NR; Wang Y
J Control Release; 2015 Jun; 207():7-17. PubMed ID: 25836592
[TBL] [Abstract][Full Text] [Related]
4. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.
Zhu H; Jiang X; Li X; Hu M; Wan W; Wen Y; He Y; Zheng X
Heart Vessels; 2016 Jun; 31(6):963-75. PubMed ID: 26142379
[TBL] [Abstract][Full Text] [Related]
5. β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
Adachi M; Watanabe M; Kurata Y; Inoue Y; Notsu T; Yamamoto K; Horie H; Tanno S; Morita M; Miake J; Hamada T; Kuwabara M; Nakasone N; Ninomiya H; Tsuneto M; Shirayoshi Y; Yoshida A; Nishimura M; Yamamoto K; Hisatome I
Circ J; 2019 Oct; 83(11):2282-2291. PubMed ID: 31527337
[TBL] [Abstract][Full Text] [Related]
6. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.
Lu ZX; Mao LL; Lian F; He J; Zhang WT; Dai CY; Xue S; Lu WG; Zhu HS
BMC Cardiovasc Disord; 2014 Apr; 14():53. PubMed ID: 24742302
[TBL] [Abstract][Full Text] [Related]
8. Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction.
Guo HD; Cui GH; Yang JJ; Wang C; Zhu J; Zhang LS; Jiang J; Shao SJ
Biochem Biophys Res Commun; 2012 Jul; 424(1):105-11. PubMed ID: 22732415
[TBL] [Abstract][Full Text] [Related]
9. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
Liu CD; Tu XF; Chen F
Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
[TBL] [Abstract][Full Text] [Related]
10. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
[TBL] [Abstract][Full Text] [Related]
11. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
12. A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing.
Arokiaraj MC
BMC Cardiovasc Disord; 2017 Jul; 17(1):209. PubMed ID: 28754088
[TBL] [Abstract][Full Text] [Related]
13. Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.
Wang Y; Liu XC; Zhao J; Kong XR; Shi RF; Zhao XB; Song CX; Liu TJ; Lu F
Tex Heart Inst J; 2009; 36(2):89-97. PubMed ID: 19436800
[TBL] [Abstract][Full Text] [Related]
14. Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration.
Qi Q; Zhu Y; Liu G; Yuan Z; Li H; Zhao Q
Biomed Pharmacother; 2020 Sep; 129():110382. PubMed ID: 32590191
[TBL] [Abstract][Full Text] [Related]
15. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Bai Y; Bai L; Zhou J; Chen H; Zhang L
Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis.
Silva EA; Mooney DJ
J Thromb Haemost; 2007 Mar; 5(3):590-8. PubMed ID: 17229044
[TBL] [Abstract][Full Text] [Related]
17. Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.
Wu M; Pokreisz P; Swinnen M; Caluwe E; Gillijns H; Vanden Driessche N; Casazza A; Verbeken E; Collen D; Janssens S
J Cardiovasc Transl Res; 2017 Aug; 10(4):348-358. PubMed ID: 28397162
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
19. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
Takeda Y; Uemura S; Iwama H; Imagawa K; Nishida T; Onoue K; Takemoto Y; Soeda T; Okayama S; Somekawa S; Ishigami K; Takaoka M; Kawata H; Kubo A; Horii M; Nakajima T; Saito Y
Circ J; 2009 Sep; 73(9):1674-82. PubMed ID: 19602778
[TBL] [Abstract][Full Text] [Related]
20. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC
Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
